HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunomodulation of airway epithelium cell activation by mesenchymal stromal cells ameliorates house dust mite-induced airway inflammation in mice.

Abstract
Allergic asthma is underpinned by T helper 2 (Th2) inflammation. Redundancy in Th2 cytokine function and production by innate and adaptive immune cells suggests that strategies aimed at immunomodulation may prove more beneficial. Hence, we sought to determine whether administration of mesenchymal stromal cells (MSCs) to house dust mite (HDM) (Dermatophagoides pteronyssinus)-sensitized mice would suppress the development of Th2 inflammation and airway hyperresponsiveness (AHR) after HDM challenge. We report that the intravenous administration of allogeneic donor MSCs 1 hour before allergen challenge significantly attenuated the features of allergic asthma, including tissue eosinophilia, Th2 cytokine (IL-5 and IL-13) levels in bronchoalveolar lavage fluid, and AHR. The number of infiltrating type 2 innate lymphoid cells was not affected by MSC transfer, suggesting that MSCs may modulate the adaptive arm of Th2 immunity. The effect of MSC administration was long lasting; all features of allergic airway disease were significantly suppressed in response to a second round of HDM challenge 4 weeks after MSC administration. Further, we observed that MSCs decreased the release of epithelial cell-derived alarmins IL-1α and high mobility group box-1 in an IL-1 receptor antagonist-dependent manner. This significantly decreased the expression of the pro-Th2 cytokine IL-25 and reduced the number of activated and antigen-acquiring CD11c(+)CD11b(+) dendritic cells in the lung and mediastinal lymph nodes. Our findings suggest that MSC administration can ameliorate allergic airway inflammation by blunting the amplification of epithelial-derived inflammatory cytokines induced by HDM exposure and may offer long-term protection against Th2-mediated allergic airway inflammation and AHR.
AuthorsKhang M Duong, Jaisy Arikkatt, M Ashik Ullah, Jason P Lynch, Vivian Zhang, Kerry Atkinson, Peter D Sly, Simon Phipps
JournalAmerican journal of respiratory cell and molecular biology (Am J Respir Cell Mol Biol) Vol. 53 Issue 5 Pg. 615-24 (Nov 2015) ISSN: 1535-4989 [Electronic] United States
PMID25789608 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Allergens
  • Interleukin-13
  • Interleukin-1alpha
  • Interleukin-5
  • Interleukins
  • Mydgf protein, mouse
Topics
  • Allergens (pharmacology)
  • Animals
  • Bronchoalveolar Lavage Fluid (chemistry, cytology)
  • Dendritic Cells (drug effects, immunology, pathology)
  • Dermatophagoides pteronyssinus (immunology)
  • Eosinophilia (etiology, genetics, immunology, therapy)
  • Female
  • Gene Expression
  • Immunomodulation (drug effects)
  • Interleukin-13 (genetics, immunology)
  • Interleukin-1alpha (genetics, immunology)
  • Interleukin-5 (genetics, immunology)
  • Interleukins (genetics, immunology)
  • Lymph Nodes (drug effects, immunology, pathology)
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells (cytology, immunology)
  • Mice
  • Mice, Inbred BALB C
  • Respiratory Hypersensitivity (etiology, genetics, immunology, therapy)
  • Respiratory Mucosa (drug effects, immunology, pathology)
  • Th2 Cells (drug effects, immunology, pathology)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: